SCHEMBL15845

SCHEMBL15845

O=S(=O)(c1ccccc1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GCK P35557 5/20 0.65
ALDH1A1 P00352 3/20 0.51
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
HSD11B1 P28845 3/20 0.49
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
NAMPT P43490 1/20 0.46
PKM P14618 1/20 0.45
GAA P10253 1/20 0.45
MCOLN3 Q8TDD5 1/20 0.45
USP2 O75604 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15855 0.82 GCKR (0.68) GCKHTTMEN1KMT2APKM
SCHEMBL16882 0.79 GCK (1.00) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL12088782 0.79 GCK (0.72) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL17392 0.78 GCKR (0.57) GCKLMNA
SCHEMBL15754 0.77 GCK (0.77) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL12079031 0.77 GCK (0.77) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL18023 0.77 GCK (0.77) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL16921 0.75 GCK (0.74) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL12078377 0.75 GCK (0.74) GCKALDH1A1HPGDHTTHSD11B1
SCHEMBL16380 0.75 GCK (0.74) GCKALDH1A1HPGDHTTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP claimed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO claimed
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed